1.92
price down icon7.69%   -0.16
after-market Handel nachbörslich: 1.92
loading
Schlusskurs vom Vortag:
$2.08
Offen:
$2.15
24-Stunden-Volumen:
54,505
Relative Volume:
0.12
Marktkapitalisierung:
$5.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.13%
1M Leistung:
-18.64%
6M Leistung:
+1.32%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$1.92
$2.15
1-Wochen-Bereich:
Value
$1.87
$2.29
52-Wochen-Spanne:
Value
$1.41
$5.30

Vivosim Labs Inc Stock (VIVS) Company Profile

Name
Firmenname
Vivosim Labs Inc
Name
Telefon
858-224-1000
Name
Adresse
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
VIVS's Discussions on Twitter

Vergleichen Sie VIVS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VIVS
Vivosim Labs Inc
1.92 5.42M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.86 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
796.55 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
398.29 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
788.49 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.97 36.31B 447.02M -1.18B -906.14M -6.1812

Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2018-12-13 Eingeleitet H.C. Wainwright Buy
2017-11-10 Herabstufung Raymond James Outperform → Mkt Perform
2017-01-25 Eingeleitet Raymond James Outperform
2015-08-11 Herabstufung Cantor Fitzgerald Buy → Hold
2015-06-29 Eingeleitet Jefferies Buy
2015-06-29 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Vivosim Labs Inc Aktie (VIVS) Neueste Nachrichten

pulisher
Jan 09, 2026

VivoSim Labs, Inc.Common Stock (NQ: VIVS - FinancialContent

Jan 09, 2026
pulisher
Jan 09, 2026

Why VivoSim Labs Inc. stock is favored by pension fundsJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Is VivoSim Labs Inc. (4OR) stock prepared for digital transition2025 Historical Comparison & Fast Entry and Exit Trade Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How VivoSim Labs Inc. stock compares to market leadersWeekly Profit Summary & High Accuracy Investment Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can VivoSim Labs Inc. stock deliver surprise earnings beatJuly 2025 Spike Watch & Smart Allocation Stock Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidateRisk Adjusted Returns & Stay Ahead With Daily Market Discussions - ulpravda.ru

Jan 07, 2026
pulisher
Jan 07, 2026

VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 06, 2026

Why VivoSim Labs Inc. stock could outperform in 20252026 world cup usa national team round of 16 playmakers set piece tactics expert forecast statistical analysis - ulpravda.ru

Jan 06, 2026
pulisher
Jan 06, 2026

Is VivoSim Labs Inc. stock affected by interest rate hikes2026 world cup usa national team semifinals defensive leaders high defensive line winner prediction preview - ulpravda.ru

Jan 06, 2026
pulisher
Jan 06, 2026

VIVS Insider Trading - Quiver Quantitative

Jan 06, 2026
pulisher
Jan 06, 2026

VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - MarketScreener

Jan 06, 2026
pulisher
Jan 06, 2026

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times

Jan 06, 2026
pulisher
Jan 06, 2026

VivoSim Labs appoints Amar Sethi as chief scientific officer - Investing.com

Jan 06, 2026
pulisher
Jan 06, 2026

Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - ulpravda.ru

Jan 06, 2026
pulisher
Dec 26, 2025

Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade

Dec 26, 2025
pulisher
Dec 20, 2025

VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World

Dec 20, 2025
pulisher
Dec 20, 2025

Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Amar Akhtar Sethi Net Worth (2025) - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks

Dec 18, 2025
pulisher
Dec 18, 2025

Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Dec 15, 2025
pulisher
Dec 12, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Dec 12, 2025
pulisher
Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser

Dec 02, 2025
pulisher
Nov 29, 2025

Momentum Shift: Is VivoSim Labs Inc. stock a safe investment in uncertain marketsWeekly Volume Report & Consistent Growth Stock Picks - moha.gov.vn

Nov 29, 2025
pulisher
Nov 21, 2025

VivoSim Labs Inc. (VIVS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Is VivoSim Labs Inc. (4OR) stock safe for risk averse investorsJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How VivoSim Labs Inc. (4OR) stock reacts to weak economy2025 AllTime Highs & Safe Entry Point Alerts - newser.com

Nov 21, 2025

Finanzdaten der Vivosim Labs Inc-Aktie (VIVS)

Es liegen keine Finanzdaten für Vivosim Labs Inc (VIVS) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):